v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
CASH FLOWS FROM OPERATING ACTIVITIES:      
Net income (loss) $ (2,414,475) $ 845,011  
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation and amortization 6,703  
Stock-based compensation 611,468  
Change in fair value - derivative liability 6,000 (1,531,000)  
Change in fair value - warrant liability (1,080,600)  
Amortization of right-of-use asset 54,318 48,552  
Unrealized loss on digital assets 613,663  
Unrealized loss on marketable securities 8,846 71,707  
Realized gain on marketable securities (37,977) (211,062)  
Change in operating assets and liabilities:      
Prepaid expenses and other current assets 156,225 645,525  
Deposits and other assets 4,734  
Accounts payable (97,898) (205,506)  
Accounts payable - related party (28,533)  
Accrued expenses and other current liabilities 87,500 (13,692)  
Lease obligations - operating leases (59,318) (51,788)  
Net cash used in operating activities (1,095,447) (1,476,150)  
CASH FLOWS FROM INVESTING ACTIVITIES:      
Proceeds from sale of marketable securities, net 2,737,484 18,100,000  
Purchase of marketable securities (2,956,466) (16,350,538)  
Net cash provided by (used in) investing activities (218,982) 1,749,462  
CASH FLOWS FROM FINANCING ACTIVITIES:      
Payment of preferred stock dividends (Series H-7 and Series I) (403,531) (3,545,971)  
Net cash used in financing activities (403,531) (3,545,971)  
Net change in cash, cash equivalents and restricted cash (1,717,960) (3,272,659)  
Cash, cash equivalents and restricted cash, beginning of period 5,092,062 16,200,157 $ 16,200,157
Cash, cash equivalents and restricted cash, end of period 3,374,102 12,927,498 5,092,062
Supplemental disclosure of cash and non-cash transactions:      
Accrual of Series H-7 convertible preferred stock dividends 24,316 494,818  
Accretion of discounts to redemption value of Series I convertible preferred stock 941,478  
Accrual of Series I Convertible Preferred Stock Dividends 190,987  
Deemed dividend Series H-7 warrants 338,915  
Accretion of discounts to redemption value of Series H-7 convertible preferred stock 1,686,854  
Accrued Series H-7 preferred stock redemption payable 6,404,587  
Supplemental disclosure of restricted cash:      
Cash and cash equivalents 3,263,540 12,818,283 4,981,798
Restricted cash 110,562 109,215 $ 110,264
Total cash, cash equivalents and restricted cash $ 3,374,102 $ 12,927,498  

Source

PDF HTML
ZIP XBRL